• TG2 synergistically drives unique in vitro fibrin cross-linking with thrombin-activated coagulation FXIII.

  • TG2 contributes to hepatoprotective extravascular fibrin(ogen) accumulation and cross-linking in acute liver injury.

Abstract

The transglutaminase coagulation factor XIII (FXIII) is critical for the stability and function of intravascular fibrin clots. Prorepair extravascular fibrin(ogen) deposits are potentially subject to cross-linking by FXIII and other transglutaminases not typically resident in plasma. However, the impact of these alternative modifiers on fibrin(ogen) structure and function is not known. We tested the hypothesis that tissue transglutaminase (TG2) modifies FXIII-directed fibrin(ogen) cross-linking in vitro and within injured tissue. Global proteomic analysis after experimental acetaminophen (APAP)-induced acute liver injury revealed that intrahepatic fibrin(ogen) deposition was associated with hepatic TG2 levels that exceeded that of FXIII. Mass spectrometry-based cross-link mapping of in vitro fibrin matrices uncovered, to our knowledge, the first evidence of synergistic fibrin(ogen) α-α cross-linking catalyzed by both transglutaminases. Fibrin(ogen) cross-linking was increased in livers from patients with APAP-induced acute liver failure. APAP-challenged TG2−/− mice displayed an altered pattern of FXIII-dependent fibrin(ogen)-γ and fibrin(ogen)-α chain cross-linking aligned with the impact of TG2 on fibrin cross-linking in vitro. This shift in fibrin(ogen) cross-linking exacerbated pathologies including hepatic necrosis and sinusoidal congestion. The results, to our knowledge, are the first to indicate that TG2 impacts FXIII-directed fibrin(ogen) cross-linking, both in vitro and in vivo. The results suggest that TG2 functions to dynamically alter the structure of extravascular fibrin(ogen) to mitigate liver damage, a novel mechanism likely applicable across types of tissue injury.

1.
Wolberg
AS
.
Fibrinogen and fibrin: synthesis, structure, and function in health and disease
.
J Thromb Haemost
.
2023
;
21
(
11
):
3005
-
3015
.
2.
Byrnes
JR
,
Wolberg
AS
.
Newly-recognized roles of factor XIII in thrombosis
.
Semin Thromb Hemost
.
2016
;
42
(
4
):
445
-
454
.
3.
Mitchell
JL
,
Mutch
NJ
.
Let's cross-link: diverse functions of the promiscuous cellular transglutaminase factor XIII-A
.
J Thromb Haemost
.
2019
;
17
(
1
):
19
-
30
.
4.
Murthy
SN
,
Wilson
J
,
Guy
SL
,
Lorand
L
.
Intramolecular crosslinking of monomeric fibrinogen by tissue transglutaminase
.
Proc Natl Acad Sci U S A
.
1991
;
88
(
23
):
10601
-
10604
.
5.
Murthy
SN
,
Lorand
L
.
Cross-linked A alpha.gamma chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase
.
Proc Natl Acad Sci U S A
.
1990
;
87
(
24
):
9679
-
9682
.
6.
McCabe
MC
,
Saviola
AJ
,
Hansen
KC
.
Mass spectrometry-based atlas of extracellular matrix proteins across 25 mouse organs
.
J Proteome Res
.
2023
;
22
(
3
):
790
-
801
.
7.
Gundemir
S
,
Colak
G
,
Tucholski
J
,
Johnson
GV
.
Transglutaminase 2: a molecular Swiss army knife
.
Biochim Biophys Acta
.
2012
;
1823
(
2
):
406
-
419
.
8.
Kopec
AK
,
Luyendyk
JP
.
Role of fibrin(ogen) in progression of liver disease: guilt by association?
.
Semin Thromb Hemost
.
2016
;
42
(
4
):
397
-
407
.
9.
Groeneveld
DJ
,
Poole
LG
,
Bouck
EG
, et al
.
Robust coagulation activation and coagulopathy in mice with experimental acetaminophen-induced liver failure
.
J Thromb Haemost
.
2023
;
21
(
9
):
2430
-
2440
.
10.
Poole
LG
,
Schmitt
LR
,
Schulte
A
, et al
.
Altered fibrinogen gamma-chain cross-linking in mutant fibrinogen-gamma(Delta5) mice drives acute liver injury
.
J Thromb Haemost
.
2023
;
21
(
8
):
2175
-
2188
.
11.
Poole
LG
,
Kopec
AK
,
Groeneveld
DJ
, et al
.
Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury
.
Blood
.
2021
;
137
(
18
):
2520
-
2531
.
12.
Kopec
AK
,
Joshi
N
,
Cline-Fedewa
H
, et al
.
Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte alphaMbeta2 integrin-dependent upregulation of Mmp12
.
J Hepatol
.
2017
;
66
(
4
):
787
-
797
.
13.
Nanda
N
,
Iismaa
SE
,
Owens
WA
,
Husain
A
,
Mackay
F
,
Graham
RM
.
Targeted inactivation of Gh/tissue transglutaminase II
.
J Biol Chem
.
2001
;
276
(
23
):
20673
-
20678
.
14.
Koseki-Kuno
S
,
Yamakawa
M
,
Dickneite
G
,
Ichinose
A
.
Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages
.
Blood
.
2003
;
102
(
13
):
4410
-
4412
.
15.
Bankhead
P
,
Loughrey
MB
,
Fernandez
JA
, et al
.
QuPath: open source software for digital pathology image analysis
.
Sci Rep
.
2017
;
7
(
1
):
16878
.
16.
Kattula
S
,
Byrnes
JR
,
Martin
SM
, et al
.
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
.
Blood Adv
.
2018
;
2
(
1
):
25
-
35
.
17.
Poole
LG
,
Pant
A
,
Baker
KS
, et al
.
Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase
.
J Thromb Haemost
.
2019
;
17
(
1
):
113
-
125
.
18.
Driever
EG
,
Stravitz
RT
,
Zhang
J
, et al
.
VWF/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure
.
Hepatology
.
2021
;
73
(
5
):
1882
-
1891
.
19.
von Meijenfeldt
FA
,
Stravitz
RT
,
Zhang
J
, et al
.
Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome
.
Hepatology
.
2022
;
75
(
3
):
623
-
633
.
20.
Ganger
DR
,
Rule
J
,
Rakela
J
, et al
.
Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality
.
Am J Gastroenterol
.
2018
;
113
(
9
):
1319
.
21.
Aleman
MM
,
Byrnes
JR
,
Wang
JG
, et al
.
Factor XIII activity mediates red blood cell retention in venous thrombi
.
J Clin Investig
.
2014
;
124
(
8
):
3590
-
3600
.
22.
McCabe
MC
,
Schmitt
LR
,
Hill
RC
, et al
.
Evaluation and refinement of sample preparation methods for extracellular matrix proteome coverage
.
Mol Cell Proteomics
.
2021
;
20
:
100079
.
23.
Schmitt
LR
,
Henderson
R
,
Barrett
A
, et al
.
Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots
.
J Biol Chem
.
2019
;
294
(
22
):
8773
-
8778
.
24.
Poole
LG
,
Kopec
AK
,
Flick
MJ
,
Luyendyk
JP
.
Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity
.
J Thromb Haemost
.
2022
;
20
(
5
):
1182
-
1192
.
25.
Yorifuji
H
,
Anderson
K
,
Lynch
GW
,
Van de Water
L
,
McDonagh
J
.
B protein of factor XIII: differentiation between free B and complexed B
.
Blood
.
1988
;
72
(
5
):
1645
-
1650
.
26.
Barsigian
C
,
Stern
AM
,
Martinez
J
.
Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators
.
J Biol Chem
.
1991
;
266
(
33
):
22501
-
22509
.
27.
Barsigian
C
,
Fellin
FM
,
Jain
A
,
Martinez
J
.
Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-linking at the hepatocyte surface
.
J Biol Chem
.
1988
;
263
(
28
):
14015
-
14022
.
28.
Fesus
L
,
Piacentini
M
.
Transglutaminase 2: an enigmatic enzyme with diverse functions
.
Trends Biochem Sci
.
2002
;
27
(
10
):
534
-
539
.
29.
Siegel
M
,
Strnad
P
,
Watts
RE
, et al
.
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury
.
PLoS One
.
2008
;
3
:
e1861
.
30.
Ramachandran
A
,
Jaeschke
H
.
Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology
.
J Clin Transl Res
.
2017
;
3
(
suppl 1
):
157
-
169
.
31.
Ganey
PE
,
Luyendyk
JP
,
Newport
SW
, et al
.
Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice
.
Hepatology
.
2007
;
46
(
4
):
1177
-
1186
.
32.
Luyendyk
JP
,
Kassel
KM
,
Allen
K
, et al
.
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis
.
Am J Pathol
.
2011
;
178
(
3
):
1117
-
1125
.
33.
Sullivan
BP
,
Kassel
KM
,
Jone
A
,
Flick
MJ
,
Luyendyk
JP
.
Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury
.
Am J Pathol
.
2012
;
180
(
6
):
2321
-
2329
.
34.
Mutch
NJ
,
Koikkalainen
JS
,
Fraser
SR
, et al
.
Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
.
J Thromb Haemost
.
2010
;
8
(
9
):
2017
-
2024
.
35.
Csosz
E
,
Bagossi
P
,
Nagy
Z
,
Dosztanyi
Z
,
Simon
I
,
Fesus
L
.
Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination
.
J Mol Biol
.
2008
;
383
:
390
-
402
.
36.
Nardacci
R
,
Lo Iacono
O
,
Ciccosanti
F
, et al
.
Transglutaminase type II plays a protective role in hepatic injury
.
Am J Pathol
.
2003
;
162
(
4
):
1293
-
1303
.
37.
Yao
Z
,
Fan
Y
,
Lin
L
,
Kellems
RE
,
Xia
Y
.
Tissue transglutaminase: a multifunctional and multisite regulator in health and disease
.
Physiol Rev
.
2024
;
104
(
1
):
281
-
325
.
38.
Tatsukawa
H
,
Fukaya
Y
,
Frampton
G
, et al
.
Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1
.
Gastroenterology
.
2009
;
136
(
5
):
1783
-
1795.e10
.
39.
Duval
C
,
Baranauskas
A
,
Feller
T
, et al
.
Elimination of fibrin gamma-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi
.
Proc Natl Acad Sci U S A
.
2021
;
118
(
27
):
e2103226118
.
You do not currently have access to this content.
Sign in via your Institution